Ophthalmology

In recent years the stem cell science has increasingly focused on mitigating the loss of vision through Ophthalmology. Cell based therapies are showing tremendous promise in mitigating many acquired and hereditary vision problems. Age-Related Macular Degeneration, in particular, is under scrutiny as a condition that is likely to respond to adult mesenchymal cell therapy.

Ophthalmology and Deployment Protocol

At the Chicago Stem Cell Institute, we have been studying the effects of SVF (rich in mesenchymal stem cells and growth factors) on various ophthalmologic conditions including Macular degeneration, retinitis pigmentosa, diabetic retinopathy, retinal detachments, Leber’s optic neuropathy and optic neuritis. In collaboration with our ophthalmology consultants, we have designed protocols for visual loss conditions that emphasize safety and efficacy.  The deployment protocol performed under local anesthesia is all done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately 3 hours.

Schedule your Consultation with Dr. Ritacca Today

Do you have additional questions on how stem cells work and how they relate to your condition?  Contact us today to schedule a no-obligation consultation with Dr. Ritacca, Founder of the Chicago Stem Cell Treatment Center.  To get the process started, simply fill out our short stem cell candidate form. Once we receive the application, a stem cell coordinator will call you to schedule your phone or in-person consultation with Dr. Ritacca. We look forward to educating you on the latest research for stem cell therapy.